📰 Abstract Code News
Abstract Code News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abstract Code. Real-time updates on events, politics, business and more.
September 29, 2023
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
September 28, 2023
/PRNewswire/ -- IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody...
June 12, 2023
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
May 15, 2023
Cereno Scientific ,a company developing innovative treatments for common and rare cardiovascular disease, today announced that an abstract on preclinical drug candidate CS585 has been... | May 15, 2023
May 11, 2023
A post-hoc subgroup analysis from the AFM13 REDIRECT study in patients with relapsed/refractory peripheral T cell lymphoma is accepted as a poster presentationA trial in progress abstract of the... | May 11, 2023
June 13, 2022
- 82% ORR (9 of 11 patients) and 82% (9 of 11 patients) CR rate documented after anbal-cel treatment to the patients in relapsed/refractory larg...
June 10, 2022
OSLO, Norway, June 10, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces an update from the LYMRIT 37-05 Phase 1 trial investigating Betalutin (177Lu lilotomab satetraxetan)
June 10, 2022
Investegate announcements from Syncona Limited, Autolus presents clinical data updates at EHA
June 10, 2022
/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces an update from the LYMRIT 37-05 Phase 1 trial investigating Betalutin® (177Lu lilotomab...
June 10, 2022
/PRNewswire/ -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and...